The Affordable Care Act (ACA) represents the most dramatic expansion of health insurance for vulnerable Americans since implementation of the Medicaid and Medicare programs in the 1960s. The legislation and accompanying regulations are complex, as they are designed to address a variety of gaps in coverage while working within existing structures for providing health insurance. Some aspects of the ACA are specifically designed to address barriers to coverage for individuals with health problems such as cancer that may keep them out of the labor force or otherwise limit access to private insurance. This session provided an overview of key components of the ACA and how they provide expanded insurance options for cancer survivors, as well as other potential impacts on out-of-pocket burdens, access to specialty providers and therapies, and enrollment in clinical trials.
Amy J. Davidoff, Ph.D.
Dr. Amy Davidoff is a health economist and health services researcher who recently joined the faculty of the Yale School of Public Health, where she is affiliated with the Yale Center for Cancer Outcomes, Public Policy and Effectiveness Research. She is also involved in several studies to evaluate the impact of the Affordable Care Act on access to cancer screening, and on treatment and health outcomes for cancer survivors. Dr. Davidoff earned her doctorate from the Johns Hopkins Bloomberg School of Public Health. She came to Yale from the Agency for Healthcare Research and Quality where she was a Senior Economist. Prior to her position at AHRQ she was an Associate Professor in Pharmaceutical Health Services Research at the University of Maryland, School of Pharmacy, and a Senior Research Associate with the Health Policy Center at the Urban Institute in Washington, D.C.